Hills Bank & Trust Co. Sells 562 Shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Hills Bank & Trust Co. lowered its stake in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) by 3.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,614 shares of the company’s stock after selling 562 shares during the quarter. Hills Bank & Trust Co. owned approximately 0.40% of Invesco Dynamic Biotechnology & Genome ETF worth $835,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. NEXT Financial Group Inc boosted its position in shares of Invesco Dynamic Biotechnology & Genome ETF by 14.1% during the 2nd quarter. NEXT Financial Group Inc now owns 2,738 shares of the company’s stock valued at $147,000 after acquiring an additional 338 shares during the last quarter. Ibex Wealth Advisors bought a new stake in Invesco Dynamic Biotechnology & Genome ETF in the 2nd quarter worth approximately $61,000. Newman Dignan & Sheerar Inc. bought a new stake in Invesco Dynamic Biotechnology & Genome ETF in the 2nd quarter worth approximately $822,000. Investment House LLC lifted its position in Invesco Dynamic Biotechnology & Genome ETF by 85.9% in the 2nd quarter. Investment House LLC now owns 9,200 shares of the company’s stock worth $492,000 after buying an additional 4,250 shares during the last quarter. Finally, PFG Advisors lifted its position in Invesco Dynamic Biotechnology & Genome ETF by 0.8% in the 2nd quarter. PFG Advisors now owns 30,392 shares of the company’s stock worth $1,599,000 after buying an additional 232 shares during the last quarter.

NYSEARCA:PBE traded up $1.25 during mid-day trading on Friday, reaching $51.68. The stock had a trading volume of 29,386 shares, compared to its average volume of 16,878. The firm has a 50 day moving average price of $49.12 and a two-hundred day moving average price of $50.78. Invesco Dynamic Biotechnology & Genome ETF has a one year low of $43.17 and a one year high of $56.65.

About Invesco Dynamic Biotechnology & Genome ETF

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

See Also: What is a Backdoor Roth IRA?

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News